Cynthia Levy

1. Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants
   2012/08/29 by Brian D. Juran, Gideon M. Hirschfield, Pietro Invernizzi +38 · 2 citations
   Medicine · #Liver Diseases and Immunity #Liver Disease Diagnosis and Treatment #Systemic Lupus Erythematosus Research #Biology #Genetics #Imputation (statistics) #Single-nucleotide polymorphism #Locus (genetics) #SNP #Haplotype #Allele #Epistasis #Genotype #Human leukocyte antigen #Genetic association #Linkage disequilibrium #Genome-wide association study #Gene #Missing data
2. Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis
   2023/12/20 by Andreas E. Kremer, Marlyn J. Mayo, Gideon M. Hirschfield +9 · 1 citation
   Medicine · #Dermatology and Skin Diseases #Liver Diseases and Immunity #Spondyloarthritis Studies and Treatments
3. Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases
   2018/11/06 by Keith D. Lindor, Christopher L. Bowlus, James Boyer +2 · 1 citation
4. Treatment options for primary biliary cirrhosis and primary sclerosing cholangitis
   2003/04/01 by Cynthia Levy, Keith D. Lindor · 1 citation
   Medicine · #Cholestasis #Chronic liver disease #Cirrhosis #Disease #Gallbladder and Bile Duct Disorders #Gastroenterology #Internal medicine #Liver Disease Diagnosis and Treatment #Liver Diseases and Immunity #Liver transplantation #Medicine #Osteoporosis #Population #Primary biliary cirrhosis #Primary sclerosing cholangitis #Transplantation #Ursodeoxycholic acid #Vitamin D and neurology